CardioVax Announces Name Change to Abcentra - PRNewswire

CardioVax Announces Name Change to Abcentra  PRNewswire

LOS ANGELES, Jan. 30, 2019 /PRNewswire/ -- CardioVax, a privately held, clinical-stage biopharmaceutical company developing novel antibody therapeutics ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases